People with advanced or metastatic cancer and their caregivers may have different care goals and face unique challenges compared with those with early-stage disease or those nearing the end of life. Recognising current survivorship care models are not designed to provide quality survivorship care for people affected by advanced or metastatic cancers, the Multinational Association for Supportive Care in Cancer (MASCC) and American Society of Clinical Oncology (ASCO) co-developed a set of international care standards with underlying objectives each supported by a series of practice recommendations for the provision of survivorship care for people affected by advanced or metastatic cancer. These standards were designed to support the optimisation of care experiences and health outcomes by providing core practice recommendations (for each standard) for adoption by a variety of stakeholders (i.e., cancer survivors, caregivers, health professionals, healthcare leaders and administrators, policymakers, health ministries, and governments worldwide) to inform best-practice clinical care, and advance research, policy, and advocacy around cancer survivorship care for those with advanced or metastatic cancer. This process resulted in the establishment of 7 Care Standards (with defined objectives) underpinned by 45 Practice Recommendations required to achieve them, endorsed by the Clinical Oncology Society of Australia (COSA). Collectively, the seven standards represent core principles of quality healthcare, providing easy-to-remember domains of care to guide routine care provision. Each care standard has been contextualised to the advanced or metastatic cancer setting through its defined objective and descriptive line-item practice recommendations which serve to provide vision, purpose, and instruction to stakeholders who oversee, resource, provide, or receive survivorship care.